LS
NBSE

Lupo Securities’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Lupo Securities’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1
Closed -$1.16K – 135
2015
Q2 		$1K Buy
+1
New +$1.08K ﹤0.01% 104
2015
Q1 		– Sell
-1
Closed -$3.3K – 705
2014
Q4 		$1.67K Buy
+1
New +$3.07K ﹤0.01% 485

Other funds holding NBSE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $138M AUM 7.66% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $88.4M AUM 15.86% 1-Year Est. Return
HF
Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Lupo Securities's NBSE Position: Q3 2015 in Review

Lupo Securities sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q3 2015, closing a stake of 1 share — an estimated $1.16K sold.

Lupo Securities first reported a position in NBSE in Q4 2014 and held it in 2 quarters. The position peaked at $1.67K in Q4 2014. 47 funds tracked by Wall St. Rank hold NBSE as of Q3 2015.

  • Lupo Securities reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Lupo Securities sold 1 NeuBase Therapeutics, Inc. Common Stock share in Q3 2015, an estimated $1.16K.
  • Lupo Securities first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q4 2014 and held it in 2 quarters.
  • Lupo Securities's NeuBase Therapeutics, Inc. Common Stock position peaked at $1.67K in Q4 2014.
  • 47 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.